Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma

Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma

Papillary thyroid carcinoma (PTC) accounts for approximately 80% of total thyroid cancers worldwide. Although the prognosis for early‐stage PTC is favorable, the 5‐year survival rate of patients with late‐stage PTC is still very poor. Cystatin SN (cystatin 1, CST1) facilitates the progression of mul...

Full description

Bibliographic Details
Main Authors: Jiaojiao Ding, Xiaorong Wang, Junxi Gao, Tao Song
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:FEBS Open Bio
Subjects:
apoptosis
cystatin SN
epithelial–mesenchymal transition
papillary thyroid carcinoma
stemness
Online Access:https://doi.org/10.1002/2211-5463.13221

Similar Items

Similar Items